Neurosteroids and GABA-A receptor function

Neurosteroids and GABA-A receptor function

Neurosteroids represent a class of endogenous steroids that are synthesized in the brain, the adrenals and the gonads and have potent and selective effects on the GABAA-receptor. 3α-hydroxy A-ring reduced metabolites of progesterone, deoxycorticosterone and testosterone are positive modulators of GA...

Full description

Bibliographic Details
Main Author:	Mingde eWang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2011-10-01
Series:	Frontiers in Endocrinology
Subjects:	Cognition mood Allopregnanolone GABA-Areceptor pregnenolone sulfate premenstrual dysphoric disorder
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fendo.2011.00044/full

Similar Items

Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle
by: Liisa Hantsoo, et al.
Published: (2020-05-01)

Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development
by: Qian Gao, et al.
Published: (2023-03-01)

Premenstrual Syndrome and Premenstrual Dysphoric Disorder as Centrally Based Disorders
by: Rossella E. Nappi, et al.
Published: (2022-03-01)

Cognition, The Menstrual Cycle, and Premenstrual Disorders: A Review
by: Jessica Le, et al.
Published: (2020-03-01)

Peak saccadic eye velocity across menstrual phases in naturally cycling women; A pilot study
by: Taran Giddey, et al.
Published: (2020-11-01)

Premenstrual dysphoric disorder: current status of treatment
by: F Lüdicke, et al.
Published: (2002-10-01)

Neurosteroids and Focal Epileptic Disorders
by: Maxime Lévesque, et al.
Published: (2020-12-01)

The endogenic neurosteroid system and its role in the pathogenesis and therapy of mental disorders
by: Sakeena P. Bairamova, et al.
Published: (2023-03-01)

Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life
by: Rachel de A. Câmara, et al.

Prevalence of premenstrual dysphoric disorder among high school girls of Gadag district, Karnataka, india- a school-based cross-sectional study
by: Nitin O Pattanashetty, et al.
Published: (2021-09-01)

Premenstrual syndrome: possibility of therapy
by: I A Kulikov, et al.
Published: (2014-04-01)

Premenstrual syndrome, dysmenorrhea, and relieving practice of female students in Prince of Songkla University
by: S Youngwanichsetha
Published: (2005-08-01)

Those few horrible days: Premenstrual syndrome
by: Gurmeet Singh Sarla
Published: (2020-01-01)

Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review
by: Amber N. Edinoff, et al.
Published: (2021-09-01)

Clinical correlates of women endorsing premenstrual suicidal ideation: a cross-sectional study
by: Sara V. Carlini, et al.
Published: (2022-11-01)

The prevalence of moderate–severe premenstrual syndrome and premenstrual dysphoric disorder and the related factors in high school students: A cross‐sectional study
by: Farzaneh Babapour, et al.
Published: (2023-06-01)

Premenstrual Syndrome and Premenstrual Dysphoric Disorder From the theory to the clinical approach
by: Danuta Maciejewska, et al.
Published: (2023-05-01)

Prevalence of premenstrual dysphoric disorder among school-going adolescent girls
by: Madhu Gupta, et al.
Published: (2019-01-01)

Neurosteroids and their role in sex-specific epilepsies
by: Doodipala Samba Reddy
Published: (2014-12-01)

Neurosteroids and GABAergic signaling in health and disease
by: MacKenzie Georgina, et al.
Published: (2013-02-01)

Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review
by: Rafał Marecki, et al.
Published: (2023-12-01)

The profile of subclinical hypothyroidism in subjects with premenstrual dysphoric disorder – A pilot study
by: S Parvathy, et al.
Published: (2021-02-01)

Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy
by: D. Samba eReddy
Published: (2011-10-01)

The Japanese Version of the Daily Record of Severity of Problems for Premenstrual Symptoms: Reliability and Validity Among the General Japanese Population
by: Takeda T, et al.
Published: (2024-02-01)

Investigating the mechanisms of Xiaoyaosan on premenstrual dysphoric disorder using metabolomics technology
by: Mengbai Xu, et al.
Published: (2024-03-01)

Protein Kinase C-Dependent Effects of Neurosteroids on Synaptic GABAA Receptor Inhibition Require the δ-Subunit
by: Erica L. Littlejohn, et al.
Published: (2021-10-01)

Study Protocol for a Randomized Double Blind, Treatment Control Trial Comparing the Efficacy of a Micronutrient Formula to a Single Vitamin Supplement in the Treatment of Premenstrual Syndrome
by: Hannah Retallick-Brown, et al.
Published: (2016-12-01)

Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life
by: Chen CY, et al.
Published: (2018-09-01)

A study of prevalence and psychological correlates of premenstrual syndrome and premenstrual dysphoric disorder
by: Arshia Jadhav, et al.
Published: (2022-01-01)

Menstrual Cycle Effects on Mental Health Outcomes: An Ethnographic Study
by: Ara Nelofar, et al.
Published: (2024-01-01)

PREMENSTRUAL SYNDROME: CLINICAL PATTERN, DIAGNOSTICS AND THERAPEUTIC APPROACHES
by: L. P. Guliyeva, et al.
Published: (2017-12-01)

The effect of Iron and vitamin D supplementation on the severity of premenstrual syndrome symptoms through High school Female Students in the City of Birjand in 2015- 2016
by: Bibi Narges Moasheri, et al.
Published: (2018-09-01)

Premenstrual syndrome and cortisol
by: Florica SANDRU, et al.
Published: (2021-03-01)

Synthetic neurosteroids on brain protection
by: Mariana Rey, et al.
Published: (2015-01-01)

Comparison of Mood, Physical Symptoms, Cognitive Failure and Life Satisfaction in Women with Premenstrual Dysphoric Disorder, Premenstrual Syndrome and No/Mild Premenstrual Syndrome: A Controlled Study
by: Selma ERCAN DOĞU, et al.
Published: (2022-10-01)

Pilot Data on the Feasibility And Clinical Outcomes of a Nomegestrol Acetate Oral Contraceptive Pill in Women With Premenstrual Dysphoric Disorder
by: Emily Robertson, et al.
Published: (2021-09-01)

Disability associated with premenstrual dysphoric disorder: A prospective study
by: Anusha Nemani, et al.
Published: (2022-01-01)

Visuospatial Function in Women with Premenstrual Dysphoric Disorder
by: Ajna Hamidovic, et al.
Published: (2024-03-01)

Premenstrual dysphoric disorder and associated factors among female health science students in Wollo University, Ethiopia, 2017/18
by: Delelegn Tsegaye, et al.
Published: (2019-05-01)

Premenstrual Dysphoric Disorder Causes Discomfort And Interfere Adolescent’s Social Relationship
by: Dewi Marfuah
Published: (2019-07-01)